FDA Approves Zydelig To Treat Three Types Of Blood Cancer

July 24, 2014 8:45 AM

9 0

FDA Approves Zydelig To Treat Three Types Of Blood Cancer

The U.S. Food and Drug Administration today approved Zydelig, a drug to treat patients with three types of blood cancers.

Zydelig can be used to treat patients whose chronic lymphocytic leukemia (CLL) has relapsed. Additionally, the drug can also be used in combination with Rituxan for patients for whom Rituxan alone would be considered appropriate therapy due to other existing medical conditions. This is the fifth ca...

Read more

To category page

Loading...